The Food and Drug Administration (FDA) has approved Caplyta ® (lumateperone) as an adjunctive therapy with antidepressants for the treatment of major depressive disorder (MDD) in adults.

In the UK, there was a case where TGN1412, an immunotherapy under development, triggered a cytokine storm within hours of administration to humans ...

A biomedical researcher combining advanced mouse models with human-based and computational approaches explains why we can’t ...

Dreyer’s Grand Ice Cream has issued a recall for Häagen-Dazs Chocolate Dark Chocolate Mini Bars after discovering the ...

The Beaufort County Sheriff’s Office made the arrests in collaboration with federal agents at the Drug Enforcement ...

Baltimore police have arrested three men after a raid of two businesses that were suspected of illegal drug sales.

Vgenomics offers RgenX, an AI-powered cloud platform that diagnoses rare genetic diseases and accelerates drug discovery by ...

Lethal lettuce in Missouri. Murderous onions in Colorado. To biochemists at the University of Oklahoma, these aren't just ...

On October 31, 2025, the Centers for Medicare & Medicaid Services (CMS) issued the physician fee schedule (PFS) final rule for calendar year (CY) ...

People who've suffered spinal cord injuries are more likely to develop an array of chronic health problems, Mass General ...

Too many Americans fall ill from contaminated food every year — and too many families experiencing tragic, preventable loss.” ...

The two main approaches for discovering disease genes reveal distinct aspects of biology, a new study shows. While both ...